Zivo Bioscience, Inc.
ZIVO
$10.00
$0.131.27%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 38.02% | 26.62% | -130.39% | -72.11% | -60.90% |
| Total Depreciation and Amortization | 8.02% | 8.02% | 8.02% | 8.02% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -98.87% |
| Total Other Non-Cash Items | -49.60% | -30.46% | 7,493.24% | 5,603.55% | 629.14% |
| Change in Net Operating Assets | 31.85% | 139.79% | -128.09% | -139.08% | 96.17% |
| Cash from Operations | 25.33% | 22.18% | 24.68% | 25.63% | 36.86% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 10.58% | -26.87% | -70.72% | -70.52% | -58.42% |
| Total Debt Repaid | 65.57% | 66.65% | 67.70% | 69.35% | -176.21% |
| Issuance of Common Stock | -26.15% | -33.94% | -16.35% | 31.05% | 5.03% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 6.38% | -21.74% | -16.54% | 30.57% | -39.56% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 92.28% | 138.71% | 641.34% | 183.15% | 30.30% |